Capital Bank & Trust’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-57
Closed -$3K – 827
2019
Q3
$3K Sell
57
-2,009
-97% -$86.6K ﹤0.01% 686
2019
Q2
$89K Buy
2,066
+66
+3% +$2.81K ﹤0.01% 371
2019
Q1
$89K Hold
2,000
– – ﹤0.01% 352
2018
Q4
$87K Sell
2,000
-380
-16% -$16.8K ﹤0.01% 360
2018
Q3
$106K Buy
2,380
+327
+16% +$14K ﹤0.01% 354
2018
Q2
$82K Hold
2,053
– – ﹤0.01% 375
2018
Q1
$82K Sell
2,053
-10
-0.5% -$416 ﹤0.01% 345
2017
Q4
$89K Buy
2,063
+63
+3% +$2.9K ﹤0.01% 367
2017
Q3
$100K Hold
2,000
– – ﹤0.01% 322
2017
Q2
$96K Buy
+2,000
New +$95.6K ﹤0.01% 310

Other funds holding SNY

Capital Bank & Trust's SNY Position: Q4 2019 in Review

Capital Bank & Trust sold out of Sanofi (SNY) in Q4 2019, closing a stake of 57 shares — an estimated $3K sold.

Capital Bank & Trust first reported a position in SNY in Q2 2017 and held it in 10 quarters. The position peaked at $106K in Q3 2018. 532 funds tracked by Wall St. Rank hold SNY as of Q4 2019.

  • Capital Bank & Trust reported no remaining Sanofi position as of Q4 2019 after selling out during the quarter.
  • Capital Bank & Trust sold 57 Sanofi shares in Q4 2019, an estimated $3K.
  • Capital Bank & Trust first reported a position in Sanofi in Q2 2017 and held it in 10 quarters.
  • Capital Bank & Trust's Sanofi position peaked at $106K in Q3 2018.
  • 532 funds tracked by Wall St. Rank held Sanofi as of Q4 2019.

Based on Capital Bank & Trust's 13F filing for Q4 2019, filed 18 Feb 2020.